Stereotaxis STXS
$ 2.34
-0.43%
Quarterly report 2024-Q3
added 11-14-2024
Country |
USA |
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSE AMERICAN |
CEO |
Mr. David Fischel |
Employees in the company |
118 |
Shares |
80.7 M |
Market Cap[1] |
$ 189 M |
EBITDA (LTM) |
$ -19.8 M |
P/E (LTM) |
-7.5 |
P/S (LTM) |
5.97 |
EPS (LTM) |
-0.28 |
Other stocks of industry "Medical instruments"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.